tirzepatide vs semaglutide effectiveness comparison efficacy of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial Tirzepatide (Zepbound; Eli Lilly and

4 A large 2025 scoping review identified hair loss as an "emerging" adverse effect worth systematic investigation, noting that most existing studies lack formal dermatologic diagnostic confirmation, meaning real-world prevalence is likely underreported

As long-term longitudinal studies play out, sometimes new impacts are found

Effect of Financial Support on Quality of Life and Medication Adherence Among Low-Income Patients Following Hospitalization For Heart Failure: The FUND-HF Trial

Lyophilized: Hold the dry vial at 20 C (4 F) in dry, dark conditions

40 cycles of denaturation at 95 for 5 s followed by annealing at 60 for 30 s

Published 2022 Oct 14